The diagnosis and management of nonalcoholic fatty liver. Type 2 Excludes. Hepatitis, unspecified. 1001/jama. – ICD-10 diagnosis codes (K74. 31 [convert to ICD-9-CM] Alcoholic cirrhosis of liver with ascites. Methods: We performed a prospective study on patients with. Type 2 Excludes. This is the American ICD-10-CM version of K74. Applicable To. 0 - other international versions of ICD-10 K70. Methods A total of 18,073 UK Biobank participants identified to have CKD (eGFR < 60 ml/min/1. NAFLD diagnoses after October. Nonalcoholic fatty liver disease (NAFLD) is a wide-spectrum disease entity from simple hepatic steatosis to nonalcoholic steatohepatitis. Opsi terapi Non-alcoholic Fatty Liver Disease (NAFLD) dan Non-alcoholic Steatohepatitis (NASH) saat ini dapat menggunakan pendekatan farmakologi dan nonfarmakologi. Browse the GARD list of rare diseases to find topics of interest. Helpline 1-800-465-4837. We assess the impact of having NAFLD on adverse clinical outcomes and all-cause mortality for people with CKD. The following code (s) above K70. K74. 81 became effective on October 1, 2021. Unlike NAFLD, NASH is characterized by significant. 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis (NASH) Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver); code, if applicable, hepatic fibrosis (K74. The definitive diagnosis of non-alcoholic steatohepatitis was established using hepatic biopsy. 9 (Unspecified chronic liver disease without mention of alcohol). diagnosis coding for overweight/obesity is low compared . 51 may differ. 571. 10. 1 is a non-billable code. 10 - other international versions of ICD-10 K72. 0, 571. 10 may differ. NAFLD is the most common liver disease in the U. As a leading cause. The 2024 edition of ICD-10-CM K74. Nonalcoholic steatohepatitis (NASH) is a common but underappreciated liver disease. 0 is a billable /specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Nonalcoholic Steatohepatitis or simply NASH is a liver condition in which fat buildup in the liver causes inflammation and liver damage [6, 13]. Pendekatan nonfarmakologi terdiri atas modifikasi gaya hidupNASH - Nonalcoholic steatohepatitis (442685003); Nonalcoholic steatohepatitis (442685003); Non-alcoholic steatohepatitis (442685003) Definition. Nonalcoholic steatohepatitis: Nonalcoholic steatohepatitis is one of the types of steatohepatitis. Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated steatotic liver disease (MASLD) affects ~70% of patients with type 2 diabetes (T2D), with ~20% showing signs of advanced liver fibrosis. 1097/MEG. Nonalcoholic steatohepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD). 10 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 401-421-3185. First discovered in 1980, non-alcoholic steatohepatitis (NASH) is a type of fatty liver disease characterized by excessive liver fat accumulation, hepatic inflammation and fibrosis ( Ludwig et al. Some patients with NAFLD progress to nonalcoholic. Nonalcoholic steatohepatitis (NASH) is part of a spectrum of conditions collectively referred to as nonalcoholic fatty liver disease (NAFLD). K76. 3%, respectively. It is viewed as largely asymptomatic in its earlier (non-cirrhotic) stages, and information on the patient-perceived impact of NASH is scarce. Non-alcoholic steatohepatitis (NASH) is a condition that falls under the umbrella of non-alcoholic fatty liver diseases (NAFLD), which are caused by fat buildup in the. Non-alcoholic steatohepatitis (NASH) refers to an advanced form of NAFLD, and it is characterized by the presence of. 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis (NASH) Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver); code, if applicable, hepatic fibrosis (K74. The differential diagnoses of alcoholic hepatitis include nonalcoholic. (protocol code no. 10 in processing claims, check the following: — See additional. alcoholic liver disease (. 81 ICD-10 code K75. 5 (Cirrhosis of liver without mention of alcohol), 571. doi: 10. To view the entire topic,. 02 - other international versions of ICD-10 K74. 0-) ICD-10-CM Diagnosis Code K75. Methods Annual deaths and age-standardized death rates (ASDR) for NALC from 1990 to 2019 were collected from the. Helpline 1-800-465-4837. Equivalent. This code description may also have Includes, Excludes, Notes, Guidelines, Examples and other information. 4. 9 - other international versions of ICD-10 K75. 31 [convert to ICD-9-CM] Alcoholic cirrhosis of liver with ascites. Hepatic fibrosis. Up to 1 in 4 individuals with NAFLD have nonalcoholic steatohepatitis, which is associated with significant morbidity and mortality due to complications of liver cirrhosis, hepatic. *571 is different from 571. 2. Evidence of NAFLD included either a NAFLD ICD -10 diagnosis code or a NAFLD NLP affirmation. [1][2][3] Although the exact cause of cryptogenic cirrhosis is unknown, there are correlations that non. Diagnoses and procedure codes appear in eTables 1-5 in Supplement 2. 0 may differ. 6 - other international versions of ICD-10 K74. ContentsK75. 69 Nature Medicine (2023) There are no approved diagnostic biomarkers for at-risk non-alcoholic steatohepatitis (NASH), defined by the presence of NASH, high histological activity and fibrosis stage. 3), primary biliary. Choose Language. NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; NFS, NAFLD fibrosis score, NLP, natural language processing. 650-736-5555. Background. Nonalcoholic steatohepatitis (NASH), a more serious form of the disease, occurs when, along with the fat build up, there is inflammation and subsequent irreversible damage to the liver. 2020 Mar 24;323 (12):1175-1183. Hepatitis B codes detected false-positive cases in patients with previous exposure (PPV 55. Excludes1: nonalcoholic steatohepatitis (NASH) K76. 5 (cirrhosis of liver without mention of alcohol). 9 became effective on October 1, 2023. Background . 0. This is the American ICD-10-CM version of K76 - other international versions of ICD-10 K76 may differ. 0) codes in the absence of any diagnosis codes for other common causes of chronic liver disease . 8 (Other. Alcoholic cirrhosis of liver. , 2022 ), accounting for 45. NAFLD is subdivided into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). . Nonalcoholic steatohepatitis is a major cause of cirrhosis and liver cancer. This was the first year ICD-10-CM was implemented into the HIPAA code set. Control diabetes. A new category, outside pure MASLD, termed MetALD (pronunciation: Met A-L-D) was selected to describe those with MASLD who consume greater amounts of alcohol per week (140 g/week and 210 g/week for females and males respectively). 9. 8 Chronic liver dis NEC. (CPT) code(s) information for each test or profile. 1–0. Nonalcoholic, fatty liver disease (NAFLD) is defined as the ectopic accumulation of fat in the liver (hepatic steatosis) when no other causes of secondary liver fat. 6 ‘Other and unspecified cirrhosis of liver’ and K75. (1,2). 9 became effective on October 1, 2023. It is found in the 2024 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2023 - Sep 30, 2024 . Patients were classified as true or false positives for NAFLD by medical chart review and the. 9 is applicable to adult patients aged 15 - 124 years inclusive. Hepatitis, unspecified. This classification algorithm was superior to an algorithm using ICD-9 data alone with AUC of 0. 81 Nonalcoholic steatohepatitis (NASH) K75. Doctors use your medical history, a physical exam, and tests to diagnose nonalcoholic fatty liver disease (NAFLD)—including nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Non-alcoholic fatty liver disease (NAFLD) is a range of liver disease characterized by the occurrence of steatosis in greater than 5% of hepatocytes of people who drink tiny or no alcohol. About Nonalcoholic steatohepatitis. Nonalcoholic fatty liver disease (NAFLD) is a disorder characterized by excess accumulation of fat in hepatocytes (nonalcoholic fatty liver (NAFL)); in up to 40% of individuals, there are. K70. Behavior changes, slurred speech, and confusion. Currently, around 25% of the population is estimated to have NAFLD, and 25% of NAFLD patients are estimated to have NASH. To prevent possible data-leakage, we only considered patient medical codes at least a month before the diagnosis of their respective ailment and manually deleted all medical codes corresponding to the diagnosis of NAFLD, NASH or liver biopsy test. 0); drug-induced idiosyncratic (unpredictable) liver disease; drug-induced toxic (predictable) liver disease; code for adverse effect, if. Zhang Y, Xing J, Liu L, Qiao F, Li J, et al. 00 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. In the United States, the number of NAFLD cases is rapidly expanding, and is expected to reach 100. Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis. 7. FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. NASH is a severe form of nonalcoholic fatty liver disease characterized by chronic inflammation and liver cell injury. 3 Proposed Model FrameworkNonalcoholic fatty liver disease (NAFLD) is an important contributor to this trend . Liver biopsy is the gold standard for diagnosis and prognosis. This is the American ICD-10-CM version of K70. (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study. 4 Peliosis hepatis K76. 573. You may have no symptoms in the early stages of NASH. ICD-9-CM Diagnosis Codes; ICD-9-Vol-3 Procedure Code; Search All Data; 2023/2024. ICD coding. 81; Fatty liver, not elsewhere classified – K76. Nonalcoholic steatohepatitis (NASH) ICD-10 codes not covered for indications listed in the CPB (not all-inclusive): K74. 5 (Cirrhosis of liver without mention of alcohol), 571. The 2024 edition of ICD-10-CM K75 became effective on October 1, 2023. However, the performance of noninvasive clinical models/scores and plasma biomarkers for the diagnosis of nonalcoholic steatohepatitis (NASH) and advanced fibrosis has not been. Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in shrsp5/dmcr rat model. Nonalcoholic steatohepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD). Most people who have NASH feel fine and don't know that they have it. 8 ICD-9 Billable. Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). K75 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. 0. Type 2 Excludes. 4 NASH was detected in 12. This is the American ICD-10-CM version of K74. Cirrhosis develops in 21% to 28 % of NASH patients compared to only 3% of patients with NAFL []. If the scarring progresses, hepatic fibrosis can become advanced, resulting in. Material and methods: We conducted a. Code Classification: Diseases of the digestive system (K00–K93) Diseases of liver (K70-K77). The existing literature regarding the relationship between OSA and nonalcoholic steatohepatitis (NASH) is conflicting. Nonalcoholic fatty liver disease, or NAFLD, refers to the buildup of excess fat in the liver. MASLD encompasses patients who have hepatic steatosis and have at least one of five cardiometabolic risk. The 2024 edition of ICD-10-CM K70. This topic will review the treatment and prognosis of NAFLD. Overview. It may lead to cirrhosis and liver failure. 0From the AFP Editors. ICD-10: K75. 0. 81 − Non-histologic criteria for the diagnosis of cirrhosis have not been established, but. K75. 81 for Nonalcoholic steatohepatitis (NASH) is a medical classification as listed by WHO under the range – Diseases of the digestive system . (non-alcoholic steatohepatitis: NASH), which can progress to cirrhosis and hepatocellular carcinoma. Nonalcoholic fatty liver disease (NAFLD) is today the most common cause of chronic liver disease and second only to viral hepatitis as a cause of liver transplantation in the U. K74. HCCs; ICD-11 NEW; SNOMED CT NEW; ICD-9-CM;K70. 2022 ICD-10-CM Diagnosis Code. According to a US population-based study of 3869 NAFLD patients and 15,209 controls, the incidence of NAFLD increased fivefold from 62 to 329 per 100,000 person-years between. 3), those with human immunodeficiency virus infection and infectious hepatitis (042 and 573. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. A 'billable code' is detailed enough to be used to specify a medical diagnosis. Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of liver diseases: 25% of the population of European countries have signs of NAFLD, 10–20% of patients with steatosis. NASH is typically characterized by liver steatosis inflammation, and fibrosis driven by metabolic disruptions. In one third of patients, the liver is enlarged and smooth, but it is not usually tender. Nonalcoholic steatohepatitis affects 3% to 6% of the US population, is more prevalent in patients with metabolic disease and obesity, progresses to cirrhosis in approximately 20% of cases, and is associated with increased rates of liver-specific and overall mortality. View ICD-10 Tree Chapter 11 - Diseases of the digestive system (K00-K95) » Diseases of liver (K70-K77) » Nonalcoholic steatohepatitis (NASH) (K75. 0 became effective on October 1, 2023. 0 became effective on October 1, 2023. Alcoholic hepatitis ranges from mild and reversible to life threatening. Tata laksana non-alcoholic fatty liver disesuaikan dengan etiologi metabolik yang mendasarinya. Nonalcoholic steatohepatitis is strongly associated with overweight or obesity and the metabolic syndrome. 81) ICD-10-CM Diagnosis Code K76. 2020; 5: 970-985. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. H. This is the American ICD-10-CM version of K74. The 2019 Standards of Medical Care in Diabetes suggested that patients with nonalcoholic fatty liver disease (NAFLD) should be evaluated for liver fibrosis. ECGs or ICD-9 code: Community-based 9333 individuals without baseline AF; aged 53–75 y: Prospective cohort: 12 y: Incident AF:. 500 results found. ICD-10-CM Diagnosis Codes. As NASH progresses and liver damage gets worse, you may start to have symptoms such as: Fatigue (feeling tired all the time). Mere deposition of fat in the liver is termed steatosis, and together these constitute fatty liver changes. 1. In the United States, the number of NAFLD cases is rapidly expanding, and is expected to reach 100. At present, clinical coding of this diagnosis requires the combination of two imprecise codes: K74. 2014. Learn how NASH can lead to some serious complications. 81 NASH code and liver biopsy); ICD-10 NASH (patients with an ICD-10 K75. miRNA is a small non-coding RNA, comprising ≤ 25 nucleotides. The 2024 edition of ICD-10-CM K71. This is the American ICD-10-CM version of K74. 0 ‘Fatty (change of) liver, not elsewhere classified (non-alcoholic fatty liver disease)’. Patients are diagnosed with NAFLD when secondary causes are not apparent (e. The need for an effective treatment is both clear and urgent, yet in the absence of proven therapies, treatment is directed toward weight loss and comorbidity management. Short description: Chronic liver dis NEC. 9, K75. J Hepatol 2011;54:1224-1229. in; a Local Coverage Determination (LCD) policy or Article ID; or a CPT/HCPCS procedure/billing code or an ICD-10-CM diagnosis code. It is associated with visceral adiposity and the metabolic syndrome and is nearly as common as type 2 diabetes. 69 became effective on October 1, 2023. Other inflammatory liver diseases. 6 may differ. e. For instance, no clear guidance exists on how to define the progression of NAFLD to cirrhosis, (i. 0); drug-induced idiosyncratic (unpredictable) liver disease; drug-induced toxic (predictable) liver disease; code for adverse effect, if. 8. Jun 09, 2023. It is unclear which specific patients progress from NAFL to NASH and, ultimately, to cirrhosis. nonalcoholic steatohepatitis (NASH) Advertise with Us | License ICD10 Data. In most clinical trials focusing on precirrhotic nonalcoholic steatohepatitis (NASH), a liver biopsy is required for confirmation of diagnosis, staging fibrosis, and grading steatohepatitis activity. 9, 571. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 8. In NAFL, hepatic steatosis is present without evidence of significant inflammation, whereas in NASH, hepatic steatosis is associated with hepatic inflammation that may be histologically indistinguishable from alcoholic steatohepatitis [. 41 - other international versions of ICD-10 K70. ICD-10- AM, International Classi cation of Diseases, Tenth Revision, Australian Modi cation; NAFLD, non- alcoholic fatty liver disease; NASH, non- alcoholic steatohepatitis; NPV, negative predictive There has been an increased interest in non-alcoholic fatty liver disease (NAFLD), and its advanced stage, non-alcoholic steatohepatitis (NASH) because of their increasing impact on global health . 2014. [3] It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to the. ICD-9-CM 571. codes reported an incidence rate for NAFLD of 29 per 100,000 person-years. Bookshelf ID: NBK470243 PMID: 29262166. 89 Other specified inflammatory liver diseases; K75. The reasons for lowlevel awareness are the relatively recent coining of the term “NASH” in 1980, the requirement of a liver biopsy for definitive diagnosis, the relatively indolent nature of the disease in most patients, and the lack of a consensus regarding histological. Alcoholic cirrhosis; Alcoholic cirrhosis of liver. Histological assessment of nonalcoholic fatty liver disease (NAFLD) is essential for clinical practice as it outlines diagnosis and lays the foundation of medical care. 502 • Gaithersburg, MD 20878. 8% of the total causes of death from chronic liver disease ( Golabi et al. 0 Non-alcoholic fatty liver disease without non-alcoholic steatohepatitis with excludes, code elsewhere, and included sections/codes. For instance, no clear guidance exists on how to define the progression of NAFLD to cirrhosis, (i. Download the app!. ICD-10-CM Coding Rules. Toll Free. 8, including coding notes, detailed descriptions, index cross-references and ICD-10-CM conversion. 2020 Dec;32(12):1566-1570. (NAFLD) can be daunting but watch how Shawanna met the challenge head on and is reversing her diagnosis with weight loss, healthy eating and exercise!Since the code for ICD-10 (International Classification of Diseases) does not have a single designation, today the most common encoding is K76. ICD-10-CM Index; ICD-10-CM External Causes Index; Table of Drugs; Table of Neoplasms; Conversion; DRG; Rules . Non-alcoholic steatohepatitis (NASH) is becoming a global disease with significant associated comorbidities. While also a condition of fat in the liver, those with nonalcoholic steatohepatitis have liver inflammation and, usually, liver cell damage as. 41 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. K72 Hepatic failure, not elsewhere classified. Other inflammatory liver diseases. Other chronic nonalcoholic liver disease. NAFLD/NASH cirrhosis may also attract code K74. Code Version: 2015 ICD-9-CM. 571. INTRODUCTION. Methods: In total, 150 patients with an ICD-10 code for NAFLD (K76. K70. Alcoholic cirrhosis with ascites; Ascites due to alcoholic cirrhosis. Nonalcoholic steatohepatitis (NASH) K75. ICD-10-CM Codes;. If your doctor feels that further confirmation is needed to make a definitive diagnosis of NASH, a liver biopsy may be ordered. Non-alcoholic steatohepatitis (NASH) is a serious chronic liver disorder of increasing prevalence worldwide. The code is valid during the current fiscal year for the. Given the inaccu-racy of administrative coding such as ICD-10, this study most likely underestimates the true incidence of NAFLD. ICD-10 codes for esophageal varices with bleeding. The following code (s) above K74. 60 - other international versions of ICD-10 K74. K75. ICD-10-CM 2023 Coding Guide™ from Unbound Medicine. 89 Other specified inflammatory liver diseases; K75. 3). K70. 3 Alcoholic liver damage, unspecified convert 571. K74. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis are associated with the buildup of fat in the liver. This is the American ICD-10-CM version of K74. 223. 0Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal liver enzymes in both adults and children. Liver biopsy is the best way to diagnose NASH and clearly shows the amount of liver damage. Our objective was to validate coding algorithms for AH using a hospitalization database. The E-DII. The aim of our study was to evaluate the efficacy of the 13C-Octanoate breath test (OBT) as a non-invasive surrogate marker to differentiate patients with NASH from patients with simple steatosis (NAFL). 75) and hepatitis C codes (κ 0. 3 result found: ICD-10-CM Diagnosis Code K75. Abstract. K70. Non-alcoholic fatty liver disease (NAFLD) consists of non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). National Digestive Diseases Information Clearinghouse . Chronic hepatitis c with stage 3 fibrosis; Chronic hepatitis c, stage 3 fibrosis; Hepatic fibrosis stage 3; underlying liver disease, such as:; nonalcoholic steatohepatitis (NASH) (K75. 8 should only be used for claims with a date of service on or before September 30, 2015. NAFLD is rapidly becoming a global health challenge, and there is a need for improved diagnostic- and prognostic tools and for effective. Non-alcoholic fatty liver disease (NAFLD) — along with its progressive form non-alcoholic steatohepatitis (NASH) — remains the most common chronic liver disease worldwide, affecting around a quarter of the adult population [1, 2]. To code a diagnosis of this type, you must use one of the two child codes of K70. 00 - K74. Nonalcoholic fatty liver disease. Clinical background. Background. ICD-9-CM 571. 0 - fatty (change of) liver, not. 8 ‘Other specified inflammatory liver diseases (non-alcoholic steatohepatitis)’ and K76. K75. Non-invasive tests (Fibrosis-4 (FIB-4) index for liver fibrosis, NAFLD fibrosis score, enhanced liver fibrosis score and. ICD-10-CM Codes; ICD-10-PCS Codes; Legacy ICD-9-CM Codes; Indexes . 9% and 45. NAFLD encompasses a spectrum of severity ranging from typically non-progressive simple steatosis or nonalcoholic fatty liver (NAFL) to. 81) K75. doi: 10. Biomarker Qualification Submission DDTBMQ000112: Imaging Biomarkers for Diagnosis of Nonalcoholic Steatohepatitis (FDA, 2021). Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as a major health burden in developed countries. It is currently the most common. NAFLD was defined using presence of 1 inpatient or 2 outpatient claims using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD‐9‐CM), claims codes. Test: 550960. 81 for Nonalcoholic steatohepatitis (NASH) is a medical classification as. Nonalcoholic steatohepatitis (NASH) Show additional info Hide additional info. Nonalcoholic Steatohepatitis (NASH): Complications. Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention Ann Transl Med. diseases (non-alcoholic steatohepatitis)’ and K76. 35% risk of morbidity and 0. The 2024 edition of ICD-10-CM K74. It is unclear which specific patients progress from NAFL to NASH and, ultimately, to cirrhosis. 0Limitations. Legacy ICD-9-CM Codes; Indexes . A recent analysis of studies involving more than 8. 8. Subcohorts for analysis were created based on (1) NASH status: biopsy-confirmed NASH (patients with an ICD-10 K75. 441 Disorders of liver except malignancy, cirrhosis or. K75. Cause of death was coded using the International Classification of Diseases (ICD) codes in use at the time of death (ICD‐8 for 1969‐1978, ICD‐9 for 1979‐1998, and ICD‐10 for 1999‐2016). doi: 10. Zoli M, Melchionda N: Metformin in non-alcoholic steatohepatitis. 8 should only be used for claims with a date of service on or before September 30, 2015. We identified the diagnosis of HCC in both study and control groups. Hepatic fibrosis. , affecting up to 25 percent of the population. Other chronic nonalcoholic liver disease. Non-Billable On/After Oct 1/2015. Liver Transplant Program. NAFLD is caused by buildup of fat in the liver. 8 (Other chronic nonalcoholic liver disease) and 571. This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). 9 million patients in 2030 (~1/3 of the. Tamimi TI, Elgouhari HM, Alkhouri N, Yerian LM, Berk MP, Lopez R, Schauer PR, Zein NN, Feldstein AE. 1–4 Steatosis and steatohepatitis are the most common morphologic patterns of liver injury in NAFLD patients.